Studies have found that VPA is able to exert its anticancer effects by altering the histone acetylation levels of tumor cells, while also downregulating the expression levels of the antiapoptotic protein survivin, counteracting its antiapoptotic effect, and playing a role in inducing tumor cell apoptosis. Here, BIRC5 is linked to neoplasm.